Factors that influence radioactive iodine use for thyroid cancer

Thyroid

Volumn 23, Issue 2, 2013, Pages 219-224

  Papaleontiou, Maria ^a   Banerjee, Mousumi ^b   Yang, Di ^b   Sisson, James C ^a   Koenig, Ronald J ^a   Haymart, Megan R ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ADULT; AGE; CANCER PATIENT; CANCER SURGERY; FEMALE; GENDER; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MORTALITY; PHYSICIAN; PRIORITY JOURNAL; REVIEW; THYROID CANCER; THYROID SURGERY;

ADULT; DECISION MAKING; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; THYROID NEOPLASMS; UNITED STATES;

EID: 84873663841     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2012.0380     Document Type: Review

References (24)

1. Siegel R, Naishadham D, Jamal A 2012 Cancer statistics. CA Cancer J Clin 62:10-29.
2. Davies L, Welch HG 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295:2164-2167.
3. Burke JP, Hay ID, Dignan F, Goellner JR, Achenbach SJ, Oberg AL, Melton LJ 3rd 2005 Long-term trends in thyroid carcinoma: a population-based study in Olmsted County, Minnesota, 1935-1999. Mayo Clin Proc 80:753-758.
4. Hodgson NC, Button J, Solorzano CC 2004 Thyroid cancer: is the incidence still increasing? Ann Surg Oncol 11:1093-1097.
5. Zhu C, Zheng T, Kilfoy BA, Han X, Ma S, Ba Y, Bai Y, Wang R, Zhu Y, Zhang Y 2009 A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973-2004. Thyroid 19:1061-1066.
6. Cancer Facts and Figures 2012 American Cancer Society. Available at www.cancer.org/Research/CancerFactsFigures/ACSPC-031941 (accessed on June 1, 2012).
7. Haymart MR, Banerjee M, Stewart AK, Koenig RJ, Birkmeyer JD, Griggs J 2011 Use of radioactive iodine for thyroid cancer. JAMA 306:721-728.
8. Iyer NG, Morris LG, Tuttle RM, Shaha AR, Ganly I 2011 Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy. Cancer 117:4439-4446.
9. Podnos YD, Smith DD, Wagman LD, Ellenhorn JD 2007 Survival in patients with papillary thyroid cancer is not affected by the use of radioactive isotope. J Surg Oncol 96:3-7.
10. Jonklaas J, Sarlis NJ, Litofsky D Ain KB, Bigos ST, Brierley JD, Cooper DS, Haugen BR, Ladenson PM, Magner J, Robbins J, Ross DS, Skarulis M, Maxon HR, Sherman SI 2006 Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid 16:1229-1242.
11. Hay ID, McConahey WM, Goellner JR 2002 Managing patients with papillary thyroid carcinoma: insights gained from the Mayo Clinic's experience of treating 2512 consecutive patients during 1940 through 2000. Trans Am Clin Climatol Assoc 113:241-260.
12. Ito Y, Masuoka H, Fukushima M, Inoue H, Kihara M, Tomoda C, Higashiyama T, Takamura Y, Kobayashi K, Miya A, Miyauchi A 2010 Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy. World J Surg 34:1285-1290.
13. Schvartz C, Bonnetain F, Dabakuyo S, Gauthier M, Cueff A, Fieffe S, Pochart JM, Cochet I, Crevisy E, Dalac A, Papathanasiou D, Toubeau M 2012 Impact on overall survival of radioactive iodine in low-risk differentiated thyroid cancer patients. J Clin Endocrinol Metab 97:1526-1535.
14. Chow SM 2005 Side effects of high-dose radioactive iodine for ablation or treatment of differentiated thyroid cancer. J HK Coll Radiol 8:127-135.
15. Van Nostrand D 2009 The benefits and risks of I-131 therapy in patients with well differentiated thyroid cancer. Thyroid 19:1381-1391.
16. Sawka AM, Thabane L, Parlea L, Ibrahim-Zada I, Tsang RW, Brierley JD, Straus S, Ezzat S, Goldstein DP 2009 Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis. Thyroid 19:451-457.
17. HaymartMR, Banerjee M, Yang D, Stewart AK, Doherty GM, Koenig RJ, Griggs JJ 2012 The relationship between extent of thyroid cancer surgery and use of radioactive iodine. Ann Surg (In press). DOI: 10.1097/SLA.0b013e31826e8915
18. Haymart MR, Banerjee M, Yang D, Stewart AK, Koenig RJ, Griggs JJ 2012 The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer. Cancer 2012 Jun 28 [Epub ahead of print]; DOI: 10.1002/cncr.27721.
19. Dillman DA 2007 Mail and Internet Surveys: The Tailored Design Method, 2nd ed. Wiley, New York.
20. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214.
21. Gilliland FD, Hunt WC, Morris DM, Key CR 1997 Prognostic factors for thyroid carcinoma: a population-based study of 15 698 cases from the Surveillance, Epidemiology, and End Results (SEER) program 1973-1991. Cancer 79:564-573.
22. Hundahl SA, Fleming ID, Fremgen AM, Menck HR 1998 A National Cancer Data Base report on 53 856 cases of thyroid carcinoma treated in the US, 1985-1995. Cancer 83:2638-2648.
23. Shnn EH, Taylor CL, Kilgore K, Valentine A, Bodurka DC, Kavanagh J, Sood A, Li Y, Basen-Engquist K 2009 Associations with worry about dying and hopelessness in ambulatory ovarian cancer patients. Palliat Support Care 7:299-306.
24. Ohaeri BM, Ofl AB, Campbell OB 2012 Relationship of knowledge of psychosocial issues about cancer with psychic distress and adjustment among breast cancer clinic attendees in a Nigerian teaching hospital. Psychooncology 21:419-426.